There Has Been a Surge in New Biomarkers During 2014

There has been a significant surge in the number of new biomarkers described in the literature during 2014. Between 2008 and 2013, the annual growth rate in publications that describe new biomarkers was 25% per year. When looking at the average number of publications...

Draft Guidance for LDTs Has Finally Been Released

In response to congressional pressure, FDA has released a copy of its long-awaited draft guidance covering regulation of LDTs. FDA seems to have addressed many if not all of the concerns regarding negative impacts from LDT regulation, at least in writing the guidance....

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access